Home Homozygosity for a DTDST mutation in a child with multiple epiphyseal dysplasia
Article
Licensed
Unlicensed Requires Authentication

Homozygosity for a DTDST mutation in a child with multiple epiphyseal dysplasia

  • Dong Wang , Jie Qin , Chenguang Zhao and Xijing He EMAIL logo
Published/Copyright: August 10, 2013

Abstract

Background: Multiple epiphyseal dysplasia (MED) is one of the common hereditary osteochondrodysplasias. Mutations in diastrophic dysplasia sulfate transporter gene (DTDST) result in recessive MED.

Objective: To investigate the possible gene mutation in a recessive MED patient.

Subjects: A boy with typical clinical features of recessive MED and his parents.

Methods: Clinical and radiological evaluations, DTDST gene sequence analysis, and sulfate uptake assay were performed on the patient and his parents.

Results: The patient showed typical symptoms of recessive MED. The radiological evaluation confirmed dysplasia in multiple epiphysis of the patient, while his parents did not show the similar clinical and radiological features. Gene sequence showed the patient was homozygous of A2092T (T689S) mutation, while his parents were both of heterozygous of the same mutation. No such mutation in DTDST gene was found in 81 normal control individuals. The patient showed reduced sulfate uptake ability in dermal fibroblast compared with his parents and normal controls.

Conclusion: The homozygous A2092T (T689S) mutation could be one of the mutations in the DTDST gene causing MED.


Corresponding author: Xijing He, MD, PhD, The Department of Orthopedics, The Second Hospital of Xi’an Jiaotong University, 157 West Fifth Road, Xi’an, Shaanxi Province, 710004, P. R. of China, Phone: +86-29-87678002 (office), +86-13909266195 (mobile), Fax: +86-29-87678634, E-mail:

We are grateful to Professor Huang Chen (Department of Genetics, Medicine college of Xi’an Jiaotong University) and Dr. Yang Xudong (Department of Biochemistry and Molecular Biology, Medicine college of Xi’an Jiaotong University) for their valuable advice to this study.

References

1. Superti-Furga A, Neumann L, Riebel T, Eich G, Steinmann B, et al. Recessively inherited multiple epiphyseal dysplasia with normal stature, club foot, and double layered patella caused by a DTDST mutation. J Med Genet 1999;36:621–4.Search in Google Scholar

2. Hastbacka J, de la Chapelle A, Mahtani MM, Clines G, Reeve-Daly MP, et al. The diastrophic dysplasia gene encodes a novel sulfate transporter: positional cloning by fine-structure linkage disequilibrium mapping. Cell 1994;78:1073–87.10.1016/0092-8674(94)90281-XSearch in Google Scholar

3. Haila S, Hastbacka J, Bohling T, Karjalainen-Lindsberg ML, Kere J, et al. SLC26A2 (diastrophic dysplasia sulfate transporter) is expressed in developing and mature cartilage but also in other tissues and cell types. J Histochem Cytochem 2001;49:973–82.10.1177/002215540104900805Search in Google Scholar

4. Rossi A, Bonaventure J, Delezoide AL, Superti-Furga A, Cetta G. Undersulfation of cartilage proteoglycans ex vivo and increased contribution of amino acid sulfur to sulfation in vitro in McAlister dysplasia/atelosteogenesis type 2. Eur J Biochem/FEBS 1997;248:741–7.10.1111/j.1432-1033.1997.t01-1-00741.xSearch in Google Scholar

5. Wallis GA. Cartilage disorders. The importance of being sulphated. Curr Biol 1995;5:225–7.10.1016/S0960-9822(95)00044-3Search in Google Scholar

6. Superti-Furga A, Hastbacka J, Wilcox WR, Cohn DH, van der Harten HJ, et al. Achondrogenesis type IB is caused by mutations in the diastrophic dysplasia sulphate transporter gene. Nat Genet 1996;12:100–2.10.1038/ng0196-100Search in Google Scholar

7. Rossi A, van der Harten HJ, Beemer FA, Kleijer WJ, Gitzelmann R, et al. Phenotypic and genotypic overlap between atelosteogenesis type 2 and diastrophic dysplasia. Hum Genet 1996;98:657–61.10.1007/s004390050279Search in Google Scholar

8. Unger S, Bonafe L, Superti-Furga, A. Multiple epiphyseal dysplasia: clinical and radiographic features, differential diagnosis and molecular basis. Best Pract Res Clin Rheumatol 2008;22:19–32.10.1016/j.berh.2007.11.009Search in Google Scholar

9. Grayeli AB, Escoubet B, Bichara M, Julien N, Silve C, et al. Increased activity of the diastrophic dysplasia sulfate transporter in otosclerosis and its inhibition by sodium fluoride. Otol Neurotol 2003;24:854–62.10.1097/00129492-200311000-00005Search in Google Scholar

10. Imauchi Y, Lombes M, Laine P, Sterkers O, Ferrary E, et al. Glucocorticoids inhibit diastrophic dysplasia sulfate transporter activity in otosclerosis by interleukin-6. Laryngoscope 2006;116:1647–50.10.1097/01.mlg.0000231733.02481.59Search in Google Scholar

11. Cai G, Nakayama M, Hiraki Y, Ozono K. Mutational analysis of the DTDST gene in a fetus with achondrogenesis type 1B. Am J Med Genet 1998;78:58–60.10.1002/(SICI)1096-8628(19980616)78:1<58::AID-AJMG12>3.0.CO;2-NSearch in Google Scholar

12. Rouached H, Berthomieu P, El Kassis E, Cathala N, Catherinot V, et al. Structural and functional analysis of the C-terminal STAS (sulfate transporter and anti-sigma antagonist) domain of the Arabidopsis thaliana sulfate transporter SULTR1.2. J Biol Chem 2005;280:15976–83.10.1074/jbc.M501635200Search in Google Scholar

13. Rossi A, Kaitila I, Wilcox WR, Rimoin DL, Steinmann B, et al. Proteoglycan sulfation in cartilage and cell cultures from patients with sulfate transporter chondrodysplasias: relationship to clinical severity and indications on the role of intracellular sulfate production. Matrix Biol 1998;17:361–69.10.1016/S0945-053X(98)90088-9Search in Google Scholar

14. Forlino A, Piazza R, Tiveron C, Della Torre S, Tatangelo L, et al. A diastrophic dysplasia sulfate transporter (SLC26A2) mutant mouse: morphological and biochemical characterization of the resulting chondrodysplasia phenotype. Hum Mol Genet 2005;14:859–71.10.1093/hmg/ddi079Search in Google Scholar PubMed

Received: 2013-1-5
Accepted: 2013-7-15
Published Online: 2013-08-10
Published in Print: 2014-01-01

©2014 by Walter de Gruyter Berlin Boston

Articles in the same Issue

  1. Masthead
  2. Masthead
  3. Editorials
  4. Editorial
  5. Consensus, guidelines and reviews
  6. Review article
  7. Adaptation of glucose metabolism to fasting in young children with infectious diseases: a perspective
  8. Images in pediatric endocrinology
  9. Coexistence of testicular microlithiasis with parathyroid adenoma in an obese child
  10. Original articles
  11. Remission of hypertension and electrolyte abnormalities following renal transplantation in a patient with apparent mineralocorticoid excess well documented throughout childhood
  12. Effects of metformin in children and adolescents with Prader-Willi syndrome and early-onset morbid obesity: a pilot study
  13. Glycemic control in familial vs. sporadic type 1 diabetes patients over 5 years
  14. Clinical and laboratory features of temporary brittle bone disease
  15. Age of thelarche and menarche in contemporary US females: a cross-sectional analysis
  16. Teriparatide (rhPTH) treatment in children with syndromic hypoparathyroidism
  17. Retinol and retinyl palmitate in fetal mice liver: sexual dimorphism
  18. Skeletal maturation and predicted adult height in children with premature adrenarche
  19. Homozygosity for a DTDST mutation in a child with multiple epiphyseal dysplasia
  20. Body composition in young patients with galactose metabolic disorders: a preliminary report
  21. Detection of vascular risk markers in children and adolescents with type 1 diabetes
  22. X-linked recessive nephrogenic diabetes insipidus: a clinico-genetic study
  23. Factors influencing neonatal thyroid-stimulating hormone concentrations as a measure of population iodine status
  24. Pediatric idiopathic intracranial hypertension and the underlying endocrine-metabolic dysfunction: a pilot study
  25. Patient reports
  26. Hypothalamic hamartoma associated with central precocious puberty and growth hormone deficiency
  27. A pediatric patient with Cushing syndrome caused by ectopic ACTH syndrome and concomitant pituitary incidentalomas
  28. A novel genetic mutation in a Portuguese family with GCK-MODY
  29. Permanent neonatal diabetes mellitus in monozygotic twins achieving low-dose sulfonylurea therapy
  30. Hypocalcemia in a paediatric case: from the clinical features to diagnosis
  31. A rare case of osteogenesis imperfecta combined with complete tooth loss
  32. Iatrogenic acute pancreatitis due to hypercalcemia in a child with pseudohypoparathyroidism
  33. Clinical expression of familial Williams-Beuren syndrome in a Turkish family
  34. The first report of cabergoline-induced immune hemolytic anemia in an adolescent with prolactinoma
  35. Low-level hyperinsulinism with hypoglycemic spells in an infant with mosaic Turner syndrome and mild Kabuki-like phenotype: a case report and review of the literature
  36. Multiple cutaneous hemangiomas in a patient with combined pituitary hormone deficiency
  37. Premature thelarche related to fennel tea consumption?
  38. A novel insertion in the FOXL2 gene in a Chilean patient with blepharophimosis ptosis epicanthus inversus syndrome type I
  39. Zellweger syndrome: prenatal and postnatal growth failure with epiphyseal stippling
  40. Marine-Lenhart syndrome in a young girl
  41. Novel AQP2 mutation causing congenital nephrogenic diabetes insipidus: challenges in management during infancy
  42. Letter to the Editors
  43. Mutational analysis of KISS1 and KISS1R in idiopathic central precocious puberty
  44. Carotid intima media thickness and echocardiography in risk stratification of obese adolescents with non-alcoholic fatty liver disease: what is the “right” approach?
  45. Vitamin D and the heart: what is the truth?
Downloaded on 22.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2013-0006/html
Scroll to top button